Surgical Management and Outcome of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus

2017 ◽  
Vol 99 (3) ◽  
pp. 267-271 ◽  
Author(s):  
Akos Berczi ◽  
Tibor Flasko ◽  
Tamas Szerafin ◽  
Ben Thomas ◽  
Zsolt Bacso ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Inferior Vena Cava ◽  
Cell Carcinoma ◽  
Surgical Management ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Vena Cava

scholarly journals Surgical Treatment Strategy with Combined Cardiopulmonary Bypass for Renal Cell Carcinoma with Tumor Embolism Developed in Inferior Vena Cava

2020 ◽  
Vol 23 (1) ◽  
pp. E025-E029
Author(s):  
Tomohiro Imazuru ◽  
Masateru Uchiyama ◽  
Tomoki Shimokawa
Keyword(s):  
Renal Cell Carcinoma ◽  
Cardiopulmonary Bypass ◽  
Inferior Vena Cava ◽  
Cell Carcinoma ◽  
Surgical Management ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Vena Cava ◽  
Significant Difference

Objective: Renal cell carcinoma (RCC) with tumor thrombus in the inferior vena cava (IVC) presents surgeons with a technical intraoperative challenge because of the need for aggressive surgical management. In this study, we describe our method for surgical management with cardiopulmonary bypass (CPB) and investigate the long-term outcomes of RCC patients with and without CPB. Methods: Fifteen patients with RCC underwent nephrectomy and IVC thrombectomy from May 2011 to December 2017. We retrospectively reviewed and analyzed the clinical course of all patients. Novick classification was used to assess the level of tumor thrombus extension into the IVC. Patient characteristics, surgical procedures, and postoperative outcome data in both groups were collected. Results: Twelve patients were male and 3 were female, with an average age of 62.9 ± 10.9 years (range 46 to 82). The average operative times were 824 ± 335 minutes in the patients with CPB and 646 ± 162 minutes in those without CPB (P = .17). The average amount of intraoperative bleeding was 2125 ± 1315 ml in the patients with CPB and 3333 ± 1431 ml in those without CPB (P = .14). The same tendency was observed in patients of Novick levels 3 and 4. The mean observation period was 1061.4 days. No 30-day mortality was noted. There was no significant difference in all-cause survival between the patients with CPB and those without. Conclusions: We conclude that surgical management with CPB and circulatory arrest may be a viable and safe method of treatment for RCC patients.

Surgical Management of Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

1997 ◽  
Vol 63 (6) ◽  
pp. 1592-1600 ◽  
Author(s):  
Jonathan C Nesbitt ◽  
Ernesto R Soltero ◽  
Colin P.N Dinney ◽  
Garrett L Walsh ◽  
David S Schrump ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Inferior Vena Cava ◽  
Cell Carcinoma ◽  
Surgical Management ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Vena Cava

scholarly journals Surgical Management of Inferior Vena Cava Tumor Thrombus in Patients with Renal Cell Carcinoma

2013 ◽  
Vol 3 (2) ◽  
pp. 47-52 ◽  
Author(s):  
Nihan Kayalar ◽  
Berk Ozkaynak ◽  
Funda Gumus ◽  
Huseyin Kuplay ◽  
Baris Nuhoglu ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Inferior Vena Cava ◽  
Cell Carcinoma ◽  
Surgical Management ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Vena Cava

Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus

2002 ◽  
Vol 183 (3) ◽  
pp. 292-299 ◽  
Author(s):  
Sadi Kaplan ◽  
Sinan Ekici ◽  
Rıza Doğan ◽  
Metin Demircin ◽  
Haluk Özen ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Inferior Vena Cava ◽  
Cell Carcinoma ◽  
Surgical Management ◽  
Renal Cell ◽  
Tumor Thrombus ◽  
Inferior Vena ◽  
Vena Cava
Sign in / Sign up

Export Citation Format

Share Document